跳转至内容
Merck

C6922

Sigma-Aldrich

Cyclohexylacetyl-Phe-Arg-Ser-Val-Gln amide

≥97% (HPLC)

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C36H58N10O8
分子量:
758.91
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:

化驗

≥97% (HPLC)

儲存溫度

−20°C

SMILES 字串

CC(C)C(NC(=O)C(CO)NC(=O)C(CCCNC(N)=N)NC(=O)C(Cc1ccccc1)NC(=O)CC2CCCCC2)C(=O)NC(CCC(N)=O)C(N)=O

InChI

1S/C36H58N10O8/c1-21(2)30(35(54)43-24(31(38)50)15-16-28(37)48)46-34(53)27(20-47)45-32(51)25(14-9-17-41-36(39)40)44-33(52)26(18-22-10-5-3-6-11-22)42-29(49)19-23-12-7-4-8-13-23/h3,5-6,10-11,21,23-27,30,47H,4,7-9,12-20H2,1-2H3,(H2,37,48)(H2,38,50)(H,42,49)(H,43,54)(H,44,52)(H,45,51)(H,46,53)(H4,39,40,41)

InChI 密鑰

CQRVUZFZOUAQCT-UHFFFAOYSA-N

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

H Okunishi et al.
Advances in experimental medicine and biology, 247B, 23-28 (1989-01-01)
Kininogen sequence analogs containing amino acid residues around the Arg-Ser cleavage site of bovine kininogens were prepared with bulky aliphatic residues in P3 position. KKI-7 (containing a cyclohexylacetyl group) and KKI-8 (containing an adamantaneacetyl group) both inhibited human urinary kallikrein
The design of specific inhibitors of tissue kallikrein and their effect on the blood pressure of the rat.
J Burton et al.
Advances in experimental medicine and biology, 247B, 9-13 (1989-01-01)
P Rebuffat et al.
Histology and histopathology, 15(2), 441-444 (2000-05-16)
The effects on the pituitary-adrenocortical functions of the prolonged (7-day) blockade of endogenous bradykinin (BK) synthesis, obtained by the administration of the kallikrein inhibitor (K-I) cyclohexylacetyl-Phe-Arg-Ser-Val-Gln amide, were investigated in the rat. K-I treatment did not cause significant changes in

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门